Updated Phase 2 Data With Flutemetamol Published In Annals Of Neurology
GE Healthcare announced that results from its multicenter phase 2 study of flutemetamol were published in the September issue of Annals of Neurology. Flutemetamol is an investigational positron emission tomography (PET) imaging agent being developed by GE Healthcare, in the field of brain imaging. The purpose of the phase 2 study was to investigate the efficacy of flutemetamol in differentiating between patients with clinically probable Alzheimer's disease (AD) and cognitively intact healthy volunteers (HVs)... (Source: Health News from Medical News Today)div id=medwormpbiMedWorm Message:/i/b Register forba href=http://www.medmatcha.com target =_selfMedMatcha, MedWorm's medical advertising network/a/b, and receive $5 free advertising./p/div
3 Out Of 4 Cats Will Wear A Collar, Making It Worth A Try
Almost three out of four cats in a new study wore collars consistently during a six-month study, suggesting that most cats will tolerate a collar even if their owners are skeptical about its success. In fact, in almost 60 percent of cases, the animals' tolerance of collars exceeded owners' expectations that their cat would keep the collar on without much trouble. The researchers suggest that, armed with this data, veterinarians should include a discussion about the importance of identification during annual wellness exams of pet cats... (Source: Health News from Medical News Today)
